ORBIMED ADVISORS LLC 13D/13G Filings for Elevation Oncology, Inc. (ELEV)

ORBIMED ADVISORS LLC 13D and 13G filings for Elevation Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
6:45 pm
Sale		 2024-09-30 13G Elevation Oncology, Inc.
ELEV		 ORBIMED ADVISORS LLC 2,441,275
4.000%		 -558,725decrease
(-18.62%)		 Filing
2024-02-14
6:42 pm
Purchase		 2023-12-31 13G Elevation Oncology, Inc.
ELEV		 ORBIMED ADVISORS LLC 3,000,000
6.800%		 3,000,000increase
(New Position)		 Filing